High Tower Advisors, LLC Bio Techne Corp Transaction History

High Tower Advisors, LLC

  • $76.8 Billion
  • Q2 2025

A detailed history of High Tower Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 6,336 shares of TECH stock, worth $407,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,336
Previous 9,818 35.47%
Holding current value
$407,088
Previous $575,000 43.48%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$46.66 - $58.38 $162,470 - $203,279
-3,482 Reduced 35.47%
6,336 $325,000
Q1 2025

May 12, 2025
SELL
$58.47 - $78.75 $98,405 - $132,536
-1,683 Reduced 14.63%
9,818 $575,000
Q4 2024

Feb 07, 2025
SELL
$66.37 - $78.17 $62,387 - $73,479
-940 Reduced 7.56%
11,501 $828,000
Q3 2024

Nov 14, 2024
SELL
$70.96 - $82.35 $154,834 - $179,687
-2,182 Reduced 14.92%
12,441 $994,000
Q2 2024

Aug 13, 2024
SELL
$62.12 - $84.15 $221,519 - $300,078
-3,566 Reduced 19.61%
14,623 $1.05 Million
Q1 2024

May 06, 2024
BUY
$65.98 - $77.09 $29,756 - $34,767
451 Added 2.54%
18,189 $1.28 Million
Q4 2023

Feb 12, 2024
SELL
$52.83 - $78.22 $59,592 - $88,232
-1,128 Reduced 5.98%
17,738 $1.37 Million
Q3 2023

Nov 08, 2023
BUY
$67.52 - $89.42 $65,156 - $86,290
965 Added 5.39%
18,866 $1.28 Million
Q2 2023

Aug 14, 2023
BUY
$73.76 - $85.98 $59,671 - $69,557
809 Added 4.73%
17,901 $1.46 Million
Q1 2023

May 11, 2023
SELL
$71.62 - $86.62 $7,520 - $9,095
-105 Reduced 0.61%
17,092 $1.27 Million
Q4 2022

Feb 08, 2023
BUY
$80.67 - $352.29 $1.05 Million - $4.6 Million
13,054 Added 315.09%
17,197 $1.43 Million
Q3 2022

Nov 09, 2022
SELL
$282.54 - $391.85 $40,685 - $56,426
-144 Reduced 3.36%
4,143 $1.18 Million
Q2 2022

Aug 10, 2022
SELL
$322.67 - $449.65 $18,714 - $26,079
-58 Reduced 1.33%
4,287 $1.47 Million
Q1 2022

May 12, 2022
SELL
$353.85 - $487.79 $81,385 - $112,191
-230 Reduced 5.03%
4,345 $1.88 Million
Q4 2021

Feb 10, 2022
BUY
$456.15 - $525.06 $68,422 - $78,758
150 Added 3.39%
4,575 $2.39 Million
Q3 2021

Nov 12, 2021
BUY
$444.87 - $538.88 $35,144 - $42,571
79 Added 1.82%
4,425 $2.12 Million
Q2 2021

Aug 06, 2021
BUY
$387.35 - $450.26 $125,501 - $145,884
324 Added 8.06%
4,346 $1.97 Million
Q1 2021

May 10, 2021
BUY
$314.62 - $411.0 $72,677 - $94,941
231 Added 6.09%
4,022 $1.54 Million
Q4 2020

Feb 10, 2021
BUY
$246.9 - $321.87 $25,430 - $33,152
103 Added 2.79%
3,791 $1.2 Million
Q3 2020

Nov 13, 2020
SELL
$232.22 - $282.96 $9,753 - $11,884
-42 Reduced 1.13%
3,688 $895,000
Q2 2020

Aug 10, 2020
BUY
$185.43 - $279.56 $56,185 - $84,706
303 Added 8.84%
3,730 $984,000
Q1 2020

May 21, 2020
BUY
$161.17 - $221.51 $16,278 - $22,372
101 Added 3.04%
3,427 $647,000
Q4 2019

Feb 14, 2020
SELL
$189.68 - $222.09 $13,087 - $15,324
-69 Reduced 2.03%
3,326 $738,000
Q3 2019

Nov 12, 2019
BUY
$183.56 - $216.72 $109,034 - $128,731
594 Added 21.21%
3,395 $667,000
Q2 2019

Aug 13, 2019
BUY
$188.72 - $215.43 $33,780 - $38,561
179 Added 6.83%
2,801 $582,000
Q1 2019

May 15, 2019
BUY
$136.09 - $200.44 $68,317 - $100,620
502 Added 23.68%
2,622 $518,000
Q4 2018

Feb 14, 2019
BUY
$132.75 - $203.8 $43,276 - $66,438
326 Added 18.17%
2,120 $304,000
Q3 2018

Nov 09, 2018
BUY
$147.44 - $204.11 $264,507 - $366,173
1,794 New
1,794 $360,000
Q4 2017

Feb 14, 2018
SELL
$121.17 - $134.75 $212,653 - $236,486
-1,755 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $199,350 - $217,233
1,755
1,755 $211,000

Others Institutions Holding TECH

# of Institutions
612
Shares Held
161M
Call Options Held
225K
Put Options Held
80.8K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.52B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email